Fragile X test results report the number of CGG repeats found in the FMR1 gene, and that number falls into one of four categories: normal (5 to 44 repeats), intermediate (45 to 54), premutation (55 to 200), or full mutation (more than 200). Your report may also include information about methylation status, mosaicism, or AGG interruptions. Each of these details changes what the result means for you or your child, so understanding the full picture matters.
The Four CGG Repeat Categories
The core number on your report is the CGG repeat count. This refers to a short DNA sequence (cytosine-guanine-guanine) that repeats a variable number of times in the FMR1 gene. Everyone has some repeats. The question is how many.
Normal (5 to 44 repeats): The gene functions properly and produces adequate protein for brain development. These alleles are stable and unlikely to expand significantly when passed to children.
Intermediate or “gray zone” (45 to 54 repeats): The gene still functions normally, and individuals in this range are not affected by Fragile X syndrome. However, intermediate alleles can undergo small expansions when passed to the next generation. About 15% of maternal transmissions and 28% of paternal transmissions show small increases in repeat size. These shifts are modest and do not jump directly to a full mutation, but over several generations, an intermediate allele could gradually expand into the premutation range.
Premutation (55 to 200 repeats): The gene is still active and produces protein, so premutation carriers do not have Fragile X syndrome. But premutation alleles are unstable, especially during maternal transmission, and can expand to a full mutation in the next generation. Premutation carriers also face their own health risks, covered below.
Full mutation (more than 200 repeats): This is the range associated with Fragile X syndrome. In nearly all cases, the expanded gene becomes chemically silenced through a process called methylation, which shuts down production of the FMRP protein the brain needs for normal development. The result is intellectual disability and the behavioral and physical features of Fragile X syndrome.
What Methylation Status Means
If your report mentions methylation, it’s telling you whether the gene has been chemically switched off. When a full mutation allele becomes methylated (which happens early in fetal development, around 10 to 12 weeks of gestation), the FMR1 gene goes silent. No gene activity means no FMRP protein, and that protein deficit is what causes the symptoms of Fragile X syndrome.
In rare cases, individuals carry a full mutation that remains unmethylated. These people continue to produce enough protein for intellectual development within the normal range, despite having more than 200 repeats. This is uncommon, but it’s one reason methylation status matters on a report. The repeat count alone doesn’t always tell the whole story.
Premutation alleles are not methylated. The gene stays active in premutation carriers, which is why they don’t have Fragile X syndrome itself, though the gene’s overactivity in this range creates different problems.
Understanding Mosaicism on Your Report
Some results describe mosaicism, which means not all cells in the body carry the same version of the gene. There are two types that may appear on a Fragile X report.
Size mosaicism means some cells have a premutation-sized allele while others have a full mutation. This happens because the expanded repeat is inherently unstable and can vary across different cell types. Methylation mosaicism means some cells carry a methylated (silenced) allele and others carry an unmethylated (active) one.
Both types of mosaicism affect how severe symptoms are. In males with size or methylation mosaicism, those with higher methylation levels (above 80%) tend to have lower IQ scores and higher rates of autism spectrum features. Males with lower methylation tend to have stronger cognitive abilities, though this isn’t guaranteed. If your report shows mosaicism, the clinical picture is more variable than a straightforward full mutation result, and the percentage of methylated cells helps predict the likely impact.
Premutation Carrier Health Risks
A premutation result (55 to 200 repeats) means you are a carrier. You won’t have Fragile X syndrome, but the premutation carries its own set of health considerations.
Fragile X-associated tremor/ataxia syndrome (FXTAS) is a progressive neurological condition that develops later in life, typically after age 50. It affects 40 to 75% of male premutation carriers and 8 to 16% of female carriers. Symptoms include tremor, balance problems, and cognitive decline.
Fragile X-associated primary ovarian insufficiency (FXPOI) affects female carriers and is defined as menopause occurring before age 40. About 20 to 25% of female premutation carriers experience this, compared to roughly 1% of the general population.
Elevated gene activity in the premutation range has also been linked to increased irritability and certain behavioral difficulties, though these effects vary widely between individuals.
Expansion Risk for Future Children
If you’re a woman with a premutation, one of the most important numbers on your report is your CGG repeat count, because it predicts the chance your child will inherit a full mutation. The higher the maternal repeat count, the greater the expansion risk.
- 55 to 74 repeats: Approximately 6% chance of expanding to a full mutation in offspring
- 75 to 89 repeats: Approximately 44% chance
- 90 repeats or more: Essentially 100% chance of full mutation expansion
Fathers with a premutation can pass it to their daughters but not their sons (since sons receive the Y chromosome). Paternal premutation alleles generally do not expand to a full mutation during transmission, so the expansion risk is primarily a maternal concern.
How AGG Interruptions Affect Stability
Some reports, particularly from newer or more detailed testing, include information about AGG interruptions. Within the CGG repeat sequence, short AGG segments normally appear every 9 to 11 repeats, breaking up the otherwise pure chain of CGG repeats. These interruptions act like anchors that help stabilize the DNA during replication.
When AGG interruptions are lost, the uninterrupted CGG stretch becomes more prone to expanding during transmission to the next generation. Two women with the same CGG repeat count can have very different expansion risks depending on how many AGG interruptions they carry. If your report includes AGG data, more interruptions generally means a lower chance of expansion to a full mutation in your children. This information is especially useful for women in the lower premutation range (55 to 80 repeats) where expansion risk is moderate and AGG status can meaningfully shift the estimate.
Why Your Report May Include Two Test Methods
Your lab report may reference two different testing techniques: PCR and Southern blot. These aren’t competing tests. They provide complementary information.
PCR is the faster, less expensive method. It accurately sizes alleles through the premutation range and can detect full mutations with newer techniques. However, PCR cannot determine methylation status.
Southern blot analysis takes longer and requires more DNA, but it detects large full mutation alleles that older PCR methods might miss, and it reveals whether those alleles are methylated. Since methylation is what actually silences the gene and causes Fragile X syndrome, Southern blot provides the clinically decisive information for full mutation results.
If your report only shows PCR results and indicates a full mutation, Southern blot is typically performed to confirm the finding and assess methylation. A complete Fragile X diagnostic workup uses both methods together, following the technical standards set by the American College of Medical Genetics and Genomics.
Female Results Can Be More Complex
Women have two X chromosomes, so a Fragile X report for a female will show two allele sizes, one from each X chromosome. A result might read something like “30/80,” meaning one allele has 30 repeats (normal) and the other has 80 (premutation).
Because of a process called X-inactivation, where one X chromosome is randomly silenced in each cell, females with a full mutation often have milder symptoms than males. Some cells will use the normal X chromosome and produce FMRP protein normally, while others use the affected X and produce none. The ratio of active normal versus affected X chromosomes varies between individuals and even between tissues, which is why symptoms in females with full mutations range from no apparent effect to moderate intellectual disability.
This variability makes female results harder to interpret from the numbers alone. A woman with a full mutation on one allele and a normal allele on the other may function in the normal intellectual range or may have learning difficulties, depending on her X-inactivation pattern.